← All trials
NCT04387071
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 15, 2020
- Primary completion
- May 15, 2022
- Completion date
- Dec 31, 2022
- First posted
- May 13, 2020
- Last posted
- May 13, 2020
- Enrollment
- 42
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Southern CaliforniaLead sponsor
- National Cancer Institute (NCI)Collaborator
- University of Southern CaliforniaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.